Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Roche, Illumina, Rapid Pathogen Screening, Veracyte, NASA, Others Win US Patents


Progenika Biopharma has been awarded US Patent No. 8,669,049, "Method and device for the detection of mutations in isolated gene sequences of the low-density lipoprotein receptor (LDL-r) which is associated with familial hypercholesterolemia."

Pedro Lopez, Karlezi Alonso, Alberto Rodrigo, Pilar Alonso, Gilberto Leal, Miguel Mieras, Sergio Fernandez, Diego Hernandez, Antonio Martinez, and Miguel Perez are named as inventors.

Clinical Genomics has been awarded US Patent No. 8,669,050, "Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma."

Robert James, Julianne Henry, Jan Kazenwadel, Nick Van Host Pellekaan, Anne MacPherson, and Susan O'Connor are named as inventors.

Rapid Pathogen Screening has been awarded US Patent No. 8,669,052, "Lateral flow nucleic acid detector."

Robert Sambursky, Uma Babu, and Robert VanDine are named as inventors.

Illumina has been awarded US Patent No. 8,669,053, "Compositions and methods for preparing oligonucleotide solutions."

John Stuelpnagel and Mark Chee are named as inventors.

The Chinese University of Hong Kong has been awarded US Patent No. 8,669,054, "Marker for gastric cancer and method for detecting gastric cancer."

Jun Yu, Joseph Sung, and Xiaoxing Li are named as inventors.

The Regents of the University of California has been awarded US Patent No. 8,669,055, "Methods and articles for strand-specific polynucleotide detection with conjugated polymers."

Guillermo Bazan and Bin Liu are named as inventors.

Veracyte has been awarded US Patent No. 8,669,057, "Methods and compositions for diagnosis of thyroid conditions."

Giulia Kennedy, Bonnie Anderson, Darya Chudova, Eric Wang, Hui Wang, Moraima Pagan, Nusrat Rabbee, and Jonathan Wilde are named as inventors.

GeneNews has been awarded US Patent No. 8,669,058, "Method of profiling gene expression in a subject having colorectal cancer."

Choong-Chin Liew is named as the inventor.

Case Western Reserve University has been awarded US Patent No. 8,669,060, "Methods and compositions for detecting cancers associated with methylation of hMLH1 promoter DNA."

Sanford Markowitz and William Grady are named as inventors.

Roche has been awarded US Patent No. 8,669,061, "Method for the prevention of carryover contamination in nucleic acid amplification technologies."

Amar Gupta, Stephen Will, Roy Bohenzky, and Janine Montiel are named as inventors.

The Johns Hopkins University has been awarded US Patent No. 8,669,062, "Disease detection by digital protein truncation assays."

Giovanni Traverso, Kenneth Kinzler, and Bert Vogelstein are named as inventors.

The National Aeronautics and Space Administration has been awarded US Patent No. 8,669,096, "System and method for isolation of samples."

Ye Zhang and Honglu Wu are named as inventors.

Longhorn Vaccines and Diagnostics has been awarded US Patent No. 8,669,240, "Biological specimen collection and transport system and method of use."

Gerald Fischer and Luke Daum are named as inventors.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.